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Abstract 
Diabetes mellitus is a disease that is becoming increasingly prevalent worldwide. In many cases, people do not have access to 
synthetic drugs and make use of teas of different plants present in different countries, in order to reduce the symptoms. The 
plant extracts may contain bioactive compounds and may also contain toxic substances harmful to the human body. Much has 
been published about plants with antidiabetic activity, identifying their bioactive compounds, but there is no work in the 
literature that identifies the mechanisms of action of the extracts or isolated compounds of the extracts for a better 
understanding of the chemical reactions that occur in patients with diabetes. Therefore, this study aims to review published 
works that have tried to show some active mechanism of the different compounds (flavonoids, saponins, polyphenols, 
vitamins, etc.), to explore these mechanisms through mathematical models that can predict the benefits of these extracts to, in 
the future, facilitate the application of these natural products into less expensive drugs. It can be concluded that many of the 
extracts and isolated compounds from different hypoglycemic plants have as main mechanisms the induction of the insulin 
secretion, the enhancement of the number of beta cells of pancreatic islets, and have antioxidant properties. 
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1. Introduction 
Type 2 diabetes mellitus is a chronic metabolic disorder 
characterized by hyperglycemia as a result of reduced 
sensitivity to the hormone insulin, predominantly present in 
the liver, adipose tissues and skeletal muscles. It is also 
characterized by either deficiency of insulin production due 
to destructive lesions of pancreatic β-cells or by cellular 
resistance to insulin (Li et al., 2015; Bahmani et al., 2014; 
Sharma et al., 2014; Manosroi et al., 2011). 
According to Sharma et al. (2014), the number of people 
suffering from the disease worldwide is estimated to be over 
173 million and this figure is likely to be increased to 300 
million or more by the year of 2025. According also to 
Diabetes International Federation, the country with the higher 
number of people with diabetes is China, with 92.3 million, 
followed by India (63 million) and USA (24.1 million). 
The pharmacological treatment of diabetes includes oral 
hypoglycemic and insulin. Today, inhibiting carbohydrate-
hydrolyzing enzymes (α-amylase and α – glucosidase) is one 
of the therapeutic approaches for decreasing postgrandial 
hyperglycemia (Tiwari and Rao, 2002 cited by Huang et al., 
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2015). Before the discovery of anti-diabetic drugs and 
insulin, diabetic patients used medicinal plants and traditional 
medicine (Ovalle-Magallanes et al., 2015; Bahmani et al., 
2014) and evidence has shown that the use of plants is a 
viable alternative for the treatment of diabetes (Vasconcelos 
et al., 2011). There are large portions of the worldwide 
population that have no access to commercial medicines 
which motivate them to use plants as an alternative for the 
treatment. Moreover, current synthetic agents and insulin 
used effectively for the treatment of diabetes are scarce 
especially in rural areas, are expensive, and have prominent 
adverse effects. Complementary and alternative approaches 
to diabetes management such as isolation of phytochemicals 
with anti-hyperglycemic activities from medicinal plants are 
therefore imperative (Elekofehinti, 2015). 
Due to the extensive use of folk medicine for various 
diseases, there are in the literature many reviews dealing with 
the use of different plants. For diabetes, Grover et al. (2002) 
have reported about 800 plants with bioactive compounds. 
These may act through different mechanisms, including the 
inhibition or stimulation of enzymatic activity and/or protein 
expression. Marles and Farnsworth (1995) listed 1200 
species that have been used to treat diabetes worldwide, and 
after twenty years Ovalle-Magallanes et al. (2015) affirmed 
that there are nearly 3500 species medicinally used in 
Mexico folk medicine, of which up to 383 species are 
employed for the treatment of type 2 diabetes mellitus. 
According to Arumugam et al. (2013), out of an estimated 
250000 higher plants, and less than 1% have been screened 
pharmacologically and very few with regard to diabetes 
mellitus. Other plants, such as the one studied by Aragão et 
al. (2010), have also been observed to have hypoglycemic 
and insulin-release stimulatory effects (Gupta et al., 1984; 
Twai and Al-Badr, 1998). Trojan-Rodrigues et al. (2012) also 
cited more than 81 species of the southern Brazil that have 
hypoglycemic effects, but no mechanisms of action were 
evaluated. Another review published by Mukherjee et al. 
(2006) was based on the Indian medicinal plants with 
hypoglycemic potential showing their bioactive compounds 
(alkaloids, imidazoline, polysaccharides, flavonoids, 
saponins and ferulic acid) and some strategies of 
mechanisms. 
For example, plants of the genus Bauhinia (Leguminosae) 
are widely distributed in most tropical countries and have 
frequently been used in folk medicine to treat several 
ailments, especially diabetes. Some of them are extensively 
used such as B. manca, B. rufences, B. forficata, B. 
cheitantha and B. splendens as tea in the diabetes treatment 
(Silva and Filho, 2002; Trojan-Rodrigues et al., 2012). 
Bahmani et al. (2014) cited some effective herbs for diabetes. 
Marles and Farnsworth (1995) also cited plants of the 
Fabaceae, Asteraceae and Lamiaceae families. 
All of these plants, cited by the authors, may operate through 
different mechanisms that effect blood sugar. Some of them 
may increase the insulin kinase, some of them may inhibit 
insulinase activity and others may increase reconstruction of 
pancreatic β cells. For example, according to Aslan et al. 
(2010), antioxidants (tannins, flavonoids, vitamins C and E, 
etc.) have been shown to prevent the destruction of β cells by 
inhibiting the peroxidation chain reaction and thus they may 
provide protection against the development of diabetes. 
Antidiabetic activity of tannins (epicatechin and catechin 
derivatives) (Perez et al., 1998), coumarins, flavonoids, 
terpenoids, arginine and glutamic acid has been confirmed by 
some studies based on experimental animal models (Marles 
and Farnsworth, 1995; Ojewole, 2002; Aslan et al., 2010). 
Moreover, fibers of plants may also interfere in the 
absorption of carbohydrates and thus have an effect on blood 
glucose (Bahmani et al., 2014). However, it is difficult to 
draw any logical conclusion on the mechanism of the 
hypoglycemic effect of such a diverse mixture of chemical 
compounds contained in the plant extracts. 
There are exceptions, such as plants that have a major active 
component that is responsible for the treatment of a specific 
disease. An example is berberine that is the major active 
component (5.2-7.7%) of Rhizoma coptidis, a popular 
traditional Chinese herb for the treatment of diabetes and 
inflammation. In 1988, the hypoglycemic effect of berberine 
was first reported when it was prescribed to treat diarrhoea in 
diabetic patients. Since then, the component has been used as 
an anti-diabetic agent in folk medicine in China. It has been 
widely studied and evidenced in patients and various animal 
models (Yin et al., 2012). 
Due to this, knowledge about medicinal plants could 
encourage the production of phytotherapeutics from different 
plants or the isolation of the bioactive molecules with known 
action mechanism. Although there are already many reviews 
published involving medicinal plants from many countries, 
they did not show the action mechanism of the extract against 
the diseases. The difficulty in understanding the mechanism 
relies on the fact that there is no homogeneity in the way that 
the studies with antidiabetic plants are conducted, which 
complicates the interpretation of the results (Frode and 
Medeiros, 2008 cited by Trojan-Rodrigues et al., 2012). 
Because of this, in the literature there are not many published 
works dealing with in vivo experiments and mathematical 
modelling of diabetes with the objective to better understand 
the effects of the drugs and the teas obtained from the 
medicinal plants and, moreover, to know the exact bioactive 
components responsible for the hypoglycemic activities. 
In order to compile all the action mechanisms, this review 
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aims to assemble different published works dealing with 
hypoglycemic plants, trying to specify the main mechanism 
to model the diabetes chemical reactions in order to 
understand the influence of the bioactive compounds and 
improve the use of natural products as medicines for 
diabetes. 
The study is divided into sections showing the active 
mechanisms of the extracts, of the bioactive compounds, 
their effect on glucose, on lipid metabolism, as AMPK 
activators and on liver morphology. 
 
2. Total Extracts as 
Hypoglycemic Agents 
There are already many studies published involving 
hypoglycemic plants originating from different parts of the 
world but in this review only the works where active 
mechanism explanation was cited are discussed. This 
highlights the importance of phytochemical and preclinical 
studies with these plants, identifying the extracts and their 
potential. 
Some of the most important extracts from the plants and their 
effects are given in Table 1 and are discussed below. 
Table 1. Biologically active extracts from plants with anti-diabetes activity. 
Extracts Plants (Scientific names) Components Effects References 
Aqueous and methanolic 
stem barks extract 
Anarcadium occidentale Terpenoids, coumarin Hypoglycemic activities Ojewole (2003) 
Decoction extracts 
Bauhinia divaricata 
Bauhinia forficata 
Bauhinia monandra 
Bauhinia megalandra 
Alkaloids, 
flavonoids 
Improve of carbohydrate 
metabolism; inhibition of 
glucose-6-phosphatase 
Silva and Filho (2002) 
80% aqueous ethanol 
extract 
Cydonia oblonga 
Helianthus tuberosus 
Alium porrum 
Coumarins, fructans, lectins, 
tannins, flavonoids, 
carotenoids, saponnins, fatty 
acids 
Inhibitory effects on kidney 
tissue; lipid peroxidation level 
Aslan et al. (2010) 
Aqueous extracts 
Anogeissus acuminata 
Catunaregam tormentosa 
Diocrescis erythroclada 
Rauwolfia serpentine 
Mimosa pudica 
Glycosides, 
Xanthones, 
Tannins, 
alkaloids 
Free radical scavenging 
activity; 
Strong antioxidant activities 
Monosroi et al. (2012) 
Aqueous extracts Octomeles sumatrana Vitamins C and E 
Increase of Slc2a2 mRNA level 
and reduction of mRNA levels 
of G6 phase 
Azahar et al. (2012) 
Alcoholic extract Cassia occidentalis 
Achrosin, emodin, 
anthraquinones, anthrones, 
apigenin, cassiolin, 
campesterol, chrysophanic 
acid, chrysoriol 
Antibacterial, antifungal, 
antidiabetic, anti-inflammatory, 
anti-mutagenic and anti-
hepatoprotective activities 
Lin et al. (2012)  
and Sharma et al. 
(2014) 
 
Ojewole (2003) cited that it is difficult to draw any logical 
conclusion on the mechanism of the hypoglycemic effect due 
to the fact that the extracts of the majority of the plants 
contain many chemical compounds present as a diverse 
group. Specifically, the author evaluated the hypoglycemic 
effect of stem-bark extracts of cashew in normal and 
streptozotocin-treated rats. The aqueous and methanolic 
extracts significantly reduced the mean basal blood glucose 
concentrations of normal and diabetic rats, but the 
methanolic one was found to be more pronounced. They 
concluded that it is difficult to definite biological activities 
via different mechanisms, but it is possible that the effects 
may be due, in part, to their terpenoid and coumarin contents. 
According to the author, the mechanism remains largely 
speculative and it is unlikely to be due to the stimulation of 
pancreatic beta-cells and subsequent secretion of insulin. It 
could be observed that an aqueous or methanolic extract is 
less potent than insulin as an antidiabetic agent, but as the 
experimental results indicate that it possesses hypoglycemic 
activity, this observation lends credence to the popular use of 
the plant. 
Babiaka et al. (2015) also cited that the presence of coumarin 
scopoletin, along with betulinic acid and acacetin as the three 
most active components of the ethanol extract of Artemisia 
afra, used in the treatment of diabetes. The same components 
were found in the acetone fraction of Senna singueana stem 
bark from South Africa, that have demonstrated anti-diabetic 
effects in a rat model against type-2 diabetes. 
In 2002, Silva and Filho made a review of the chemical 
composition of plants of the Bauhinia family, because they 
are famous to have hypoglycemic effects and a large number 
of citations. One of the plants studied was B. divaricata, 
whose infusion at 20% reduced glycemia by 39% and the 
authors attributed this effect to the presence of the alkaloid 
trigoneline. However there is no application to an animal 
170 Marisa F. Mendes and I. David L. Bogle:  Evaluation of the Effects and Mechanisms of Bioactive Components Present in  
Hypoglycemic Plants 
model to confirm this. Another famous plant is the B. 
forficata that presents the major number of publications 
involving hypoglycemic activity. Pepato et al. (1998), cited 
by Silva and Filho (2002), analysed the plant decoction (150 
g/L) and orally administrated the extract to diabetic rats. The 
animals showed an improvement in the carbohydrate 
metabolism verified by the lower levels of glycaemia and 
glycosuria. A hypoglycemic effect, higher than insulin, was 
observed by the alcoholic extracts (500 mg/Kg) of B. 
monandra, reducing the glycaemic level in mice. The 
inhibition of glucose-6-phosphatase was observed by the 
aqueous extract of B. megalandra and this effect seemed to 
be related by the presence of some flavonoids. 
Three plants from Turkey were studied by Aslan et al. (2010), 
Cydonia oblonga (CO), Helianthus tuberosus (HT) and 
Allium porrum (AP), because of their special composition, 
like coumarins, fructans, lectins, tannins, flavonoids, 
carotenoids, saponins and fatty acids. Extracts with 80% 
aqueous ethanol were administrated to diabetes induced rats 
and CO and AP extracts resulted in remarkable hypoglycemic 
effect, reducing the blood glucose concentration although HT 
extracts increased blood glucose level. Diabetic rats showed 
a marked increase in lipid peroxidation in kidney, liver and 
heart tissues compared to the non-diabetic control group. The 
rats treated with the extracts showed a significant reduction 
in the level of lipid peroxidation. HT and AP extracts also 
showed an inhibitory effect on kidney tissue lipid 
peroxidation level. However, all of the extracts were found 
inactive for non-protein sulphlydryl groups (GSH) levels on 
kidney, liver, and heart tissues of diabetic rats. The authors 
commented that the reason this situation might arise is from 
the short time of the experiments. It is possible therefore to 
say that the extracts are insufficient for cellular antioxidant 
defense but might possess another mechanism of antioxidant 
action along with antilipidperoxidative activity. Further 
studies are necessary to determine the exact nature of the 
active principles and the active mechanism of the plant 
extracts. 
The same lipid peroxidation activity studied by Aslan et al. 
(2010) was observed by Monosroi et al. (2011) who tested 
various Thai plants (Anogeissus acuminata AA; 
Catunaregam tormentosa CT; Dioecrescis erythroclada DE; 
Rauwolfia serpentine RS; Mimosa pudica MP). Aqueous 
extracts of the plants revealed high contents of glycosides, 
xanthones, tannins and alkaloids. The AA extract showed the 
highest free radical scavenging activity which was 4 times 
that of ascorbic acid (control). All of the extracts reduced the 
blood glucose level compared with the standard drugs used in 
the experiments, insulin and glibenclamide, although AA 
caused the following reduction: 78.98%, RS 66.60%, CT 
59.00%, DE 55.51% and MP 50.36%. The better 
performance of AA extract could be explained by the 
evidence that strong antioxidant activities of some plants may 
be responsible for many biological properties (Saghizadeh et 
al., 1996). However the quantity of AA extract used was 
higher than the other drugs, which emphasizes that the 
potency and reaction mechanism was lower and different. 
The AA extract may have aided glucose reduction by 
improved receptor responsiveness of insulin glucose uptake 
by the tissue in diabetic mice. It may have mimicked 
thiazolidiendiones in its reaction mechanism, as observed by 
other studies (Ojewole, 2006). Ullah et al. (2015) made a 
review based on the oxidative stress describing the benefit 
effects of vitamins and other antioxidants in diabetes 
mellitus, confirming the experimental observations of Aslan 
et al. (2010) and Monoroi et al. (2011). 
Although Octomeles sumatrana is a plant commonly used as 
tonic in Malaysia, Azahar et al. (2012) studied its 
hypoglycemic effect and its molecular mechanisms 
administering the aqueous extract in diabetic induced mice. 
Treatment with the extract caused a significant increase in the 
expression of Slc2a2 mRNA level (essential for glucose 
secretion) at doses of 0.3 and 0.5 g/Kg, compared to diabetic 
rats in the control sample. mRNA levels of G6Pase was 
significantly reduced in extract treated groups at doses of 0.3 
and 0.5 g/Kg by 53 and 63%, respectively, compared to the 
diabetic untreated group. As the insulin level was not 
measured in this work, the authors made some hypothetical 
suggestions that the plasma glucose lowering effect in the 
absence of plasma insulin concentration suggests that the 
plant extract may involve an insulin independent mechanism. 
Lin et al. (2012) and Sharma et al. (2014) studied the 
hypoglycemic potential of alcoholic root extract of Cassia 
occidentalis, a common weed from South India, Burma and 
Sri Lanka. It is known to possess antibacterial, antifungal, 
antidiabetic, anti-inflammatory, anti-mutagenic and 
hepatoprotective activity. A wide range of chemical 
compounds have been isolated from this plant (Yadav et al., 
2010). The results showed that the animals treated with the 
extract of the plant have increased their body weight 
compared to diabetic control and recovered the body weight 
significantly toward normal level which may be due to the 
lipid lowering activity of the extract. Moreover, the extracts 
showed hypoglycemic activity because the total β-cell mass 
reflects the balance between the renewal and loss of these 
cells. Because of this, the decrease in blood glucose level 
may be due to potentiation of insulin effect either by increase 
in pancreatic secretion of insulin from beta cells or by 
increase in peripheral glucose uptake. 
Among all of the plants cited by many authors, Malmea 
depressa is widely used in southeast Mexico and was studied 
by Andrade-Cetto et al. (2008). They identified 2 
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phenylbutane derivatives and 1 phenylpropane derivative, but 
they did not prove the effect of these substances, only the 
effects of the butanolic extracts of the plant. Although the 
oral administration of the extract to rats led to a reduction in 
the blood glucose and triglyceride levels and increased the 
plasma insulin levels compared to the control group and to 
the group administrated by a synthetic drug, there is no 
suggestion about the mechanism action of the extract. 
Research like this is common in the literature, showing some 
evidence of hypoglycemic activity, but not explaining the 
probable chemical reactions that cause the effects. Another 
example is the work of Vargas et al. (2010) on abajeru 
(Chrysobalanus icaco) extracts obtained using supercritical 
fluid at different conditions of temperature and pressure. The 
authors did not prove the effect of the extracts because there 
were no experimental models, but the composition of the 
extracts (sterols, vitamins, triterpenes and flavones) revealed 
why the plant is widely used in folk medicine as a tea to treat 
diabetics. 
3. Bioactive Compounds 
Affecting Glucose and Lipid 
Metabolism 
Table 2. The most biologically active natural compounds with proven anti-diabetes activity. 
Plants (Scientific names) Natural compounds class Effects References 
Camelia sinensis catechins 
Inhibition of lipid peroxidation Sabu et al. (2002) 
Inhibition of intestinal glucose uptake Kobayashi et al. (2000) 
Improve of beta cell function and 
stimulation of insulin secretion 
Increased expression level of GLUT4 
transporter 
Tang et al. (2013) 
Penthorum chinense polyphenols 
Regulation of insulin secretion and 
DPPH free radical scavenging ability 
Huang et al. (2015) 
Stevia rebaudiana Bertoni 
polyphenols 
Antioxidant and antidiabetic properties 
/ increase the number of beta cells 
Shivanna et al. (2013) 
Vitamin C and E 
Synergic effects that reduce the 
production of reactive oxygen species 
Acacia Arabica, Gentiana olivieri, 
Biophytum sensitivum, Caelsalpinia 
bonducella, Catharanthus roseus, Ficus 
bengalensis, Ceropia obtusifolia 
Chlorogenic acid  
Isoorientin 
Potent antioxidant activity 
Stimulation of pancreatic beta cell to 
release insulin 
Andrade-Cetto and Heirich 
(2005) 
Andrade-Cetto and Wiedenfeld 
(2000) 
Revilla-Monsalve et al. (2007) 
Plants (Scientific names) Natural compounds class Effects References 
Cecropia pachystachya Chlorogenic acid 
Inhibitor of the glucose-6-phosphate 
translocase component 
Schwab et al. (2001) 
Anarcadium occidentale 
Stigmast-4-en-3-ol and 
stigmast-4-en-3-one 
Hypoglycemic effect Alexander-Lindo et al. (2004) 
Anoda cristata flavonoids 
Inhibitory activity against α-
glycosidade 
Juarez-Reyes et al. (2015) 
Morus multicaulis Perr. 
Deoxynojirimycin 
polysaccharide 
Increase the conversion of glucose-6-
phosphatase in glycogen 
Restore the damaged pancreas to 
normalcy 
Li et al. (2015) 
Astragalus membranaceus 
Discorea polygonoids 
Trigonella foenumgraecum 
saponins 
Enhancement of antioxidant activity 
Increase of expression of Glut4 
Elekofehinti (2015) 
Swietenia humilis 
limonoids 
Activation of glycogen synthesis Ovalle-Magallanes et al. (2015) 
Swietenia macrophylla Triglycerides reduction in blood Dwanjee et al. (2009) 
 
The previous section mentioned works which evaluated the 
behaviour of the total extract of the plant. This section shows 
the compounds found in the extracts that are reported to be 
responsible for hypoglycemic effects. Many studies can be 
found involving flavonoids, polyphenols, polysaccharides, 
limonoids and saponins as the major important components 
that have direct relationship with the reduced glucose level in 
the blood. 
Although there is a list of natural anti-diabetes possible 
drugs, citing all natural antidiabetic plants and their 
components is out of the scope of this paper. So, we have 
summarized in Table 2 only the most biologically active 
metabolites with proven anti-diabetes activity. 
3.1. Catechins 
Various polyphenols were found in different plants such as 
the catechins (for example, gallocatechin, epigallocatechin, 
epicatechin, epigallocatechin gallate and epicatechin gallate) 
present in many different teas. In 2002, Sabu et al. studied 
the effect of the polyphenols present in the aqueous extract of 
Camellia sinensis in diabetic mice induced by alloxan. They 
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was found to inhibit lipid peroxidation because the 
glutathione content in the liver of the rats increased and 
consequently reduced glucose level in the rats was observed. 
The same behaviour was demonstrated by Gomes et al. 
(1995) who had studied the anti-hyperglycemic effect of 
black tea. Kobayashi et al. (2000) showed that 
epigallocatechin gallate was found to inhibit intestinal 
glucose uptake by a sodium dependent glucose transporter. 
Other green (GTE) and black (BTE) tea extracts were also 
studied by Tang et al. (2013), because of their anti-diabetic 
activities applied to an animal model and the mechanisms 
were explored by a homeostatic model assessment (HOMA). 
They used five weeks old mice and the tests were conducted 
for 12 weeks. Generally, both BTE and GTE were highly 
effective in lowering blood glucose to levels of the normal 
group. Moreover, insulin resistance (IR) and β cell function 
(B%) were evaluated using the HOMA model based on the 
assumption that the relationship between glucose and insulin 
in the basal state reflects the balance between hepatic glucose 
output and insulin secretion. From the results, IR increased in 
the diabetic group, and GTE could supress the increase but 
BTE could not. β cell function was significantly elevated by 
BTE treatment and was raised to three times higher than the 
diabetic group. For the group treated with GTE, it was also 
higher but not significantly different.  
GTE and BTE exerted their hypoglycemic effects by 
different mechanisms and according to the authors the 
difference in the composition of the two teas accounts for the 
discrepancy in their mechanistic pathway. GTE could 
decrease IR while for BTE was mainly through stimulating 
insulin secretion and maintaining β cell function. This can be 
explained by the presence of catechins in the chemical 
analysis, which is 71.5% in GTE, while in BTE only 15.3%. 
Also, pancreatic sections of diabetic mice fed with BTE 
showed regeneration of β cells. Thus, the authors concluded 
that the BTE helps in regeneration of a damaged pancreas 
and protects pancreatic β cells by its antioxidant action 
against nitrosative stress. BTE has been found to quench 
reactive oxygen species such as singlet oxygen, superoxide 
and hydroxyl radicals, which may explain its hypoglycemic 
activity. 
Wu et al. (2004), cited by Tang et al. (2013) concluded that 
the alleviation of IR by GTE is associated with the increased 
expression level of GLUT4 transporter in a fructose-fed rat 
model and similar results were found in a dog model (Serisier 
et al., 2008 cited by Tang et al., 2013). 
3.2. Chlorogenic Acid 
Another polyphenol with hypoglycemic effect is chlorogenic 
acid, whose effect was tested by Ivorra et al. (1989), and 
demonstrated in diabetic rats. It is identified as an inhibitor of 
the glucose-6-phosphate translocase component, and this 
behaviour results in a reduction of hepatic glucose production 
(Schwab et al., 2001). According to the authors, flavonoids 
and other polyphenols are also able to act as antioxidants as 
they have the ability to scavenge free radicals. Other 
evidence of the chlorogenic acid effect was observed by 
Aragão et al. (2010) who studied a plant from Central and 
South America and widely used in Brazil, Cecropia 
pachystachya. In alloxan-induced diabetic rats, the 
methanolic extract caused a significant effect reducing the 
glycemic levels after 12 hours with a blood glucose reduction 
of 68%. The same extract had no effect on blood glucose in 
normal rats. As alloxan causes a reduction in insulin release 
by the destruction of the β-cells, inducing hyperglycemia, the 
authors suggested that the action of the extract is an 
extrapancreatic mechanism. However there were no insulin 
measurements. 
Chlorogenic acid was also cited by Andrade-Cetto and 
Heirich (2005) who presented a review of Mexican plants 
with hypoglycemic effect, showing the main bioactive 
compounds. The possible mechanism of action was attributed 
to the presence of chlorogenic acid and also isoorientin. The 
second molecule was isolated by Andrade-Cetto and 
Wiedenfeld (2000). The hypoglycemic effect of the plant 
would have been caused by the liver not providing glucose 
due to the action of the acid during the fasting of the animals. 
In relation to the isoorientin, Deliorman-Orhan et al. (2003), 
cited by Andrade-Cetto and Heinrich (2005), tested the 
hepatoprotective activity of Gentiana olivieri and concluded 
that the effect might possibly be due to the potent antioxidant 
activity of the compound. Among all the plants presented in 
the study, seven of them stimulate pancreatic beta cells to 
release insulin (Acacia arabica, Aloe vera, Biophytum 
sensitivum, Caelsalpinia bonducella, Catharanthus roseus, 
Ficus bengalensis L., Hibiscus rosa sinensis). Moreover, 
Revilla-Monsalve et al. (2007) tested the hypoglycemic 
effect of Ceropia obtusifolia Bertol and concluded that 
isoorientin and chlorogenic acid were also responsible for the 
main effects. 
3.3. Saponins 
Saponins were well studied by Elekofehinti (2015) who 
published a review showing various saponins and their origin 
as significant effects on glucose metabolism. Astragaloside, 
present in Astragalus membranaceus, inhibits hepatic 
glucogen phosphorylase and glucose 6 phosphatase activities 
and expression of their genes and improves insulin 
resistance. Diosgenin, present in two different plants, 
Discorea polygonoids and Trigonella foenum-graecum, has 
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two different effects on glucose metabolism. When it is 
present in the first plant, it increases pyruvate kinase activity 
and inhibits glucose 6 phosphatase activity, but when it is 
present in the extract of the second plant, it decreases insulin 
resistance and inhibits carbohydrate digestion/absorption. 
Terminalia arjuna contains in its extract arjunolic acid, which 
inhibits α-amylase and α-glucosidade activity. Platyconic 
acid, present in Platycodi radix, enhances insulin sensitivity, 
increases glucogen accumulation and increases Glut4 
translocation into membranes.  
In general, the hypoglycemic action of saponins is through 
restoration of insulin response, improvement in insulin 
signalling, increased plasma insulin levels and induction of 
insulin release from the pancreas, inhibition of disaccharide 
activity, activation of glycogen synthesis, inhibition of 
gluconeogenesis, inhibition of α-glucosidase activity, 
inhibition of mRNA expression of glycogen phosphorylase 
and glucose 6 phosphatase and the increase of expression of 
Glut4. Moreover, as saponins contain in its structure many -
OH groups, they are responsible for enhancement of 
antioxidant activity and this property is responsible for the 
prevention of reactive oxygen species formation in diabetes. 
This is important because many works have shown a direct 
consequence of hyperglycemia in diabetes (Elekofehinti; Li 
& Gong, 2015). 
3.4. Other Polyphenols 
Three polyphenols can be isolated from Penthorum chinense, 
a plant widely distributed in eastern Asia, such as China, 
Japan, Korea, and eastern Russia (Huang et al., 2015). The 
extracts were administrated to diabetic rats in order to 
compare with a control. All of the results referring to α-
amylase inhibition and blood glucose levels were better than 
the control. A dose of 300 mg/Kg of the extract was sufficient 
to decrease the blood glucose from the first week to the 
second in comparison to the diabetic control animals. 
Moreover, a significant increase of insulin was observed after 
the administration of the extract, suggesting that the 
regulation of insulin secretion might be one of the factors 
responsible for the anti-diabetic activity of the plant. Two of 
the polyphenols showed a remarkable DPPH free radical 
scavenging ability which also indicates the anti-diabetic 
activity of the extract due to the anti-oxidative stress effect 
(Nimse & Pal, 2015). 
Other polyphenols and compounds such as dicaffeoylquinic 
acid, chlorogenic acid, quercetin 3-O-xyloside, apigenin-7-O-
glucoside, 3,4-dimethoxycinnamic acid, luteolin 7-O-
rutinoside, caffeic acid were isolated from a plant called 
Stevia rebaudiana Bertoni, extensively used in diabetes 
treatment. Due to this Shivanna et al. (2013) studied the 
potential of the ethanol extract in relation to the antioxidant 
and antidiabetic properties. Wheeler et al. (2008) found two 
other polyphenols in the same plant, rebaudioside A and 
stevioside, present in leaf extract and the hypoglycemic effect 
was attributed to them. However, these components were not 
present in the Shivanna’s et al. (2013) study. Although 
peroxidation was reduced significantly in rats fed with stevia 
leaves powder and polyphenols compared to diabetic group, 
it reduced the elevated levels of blood glucose by 36.64% 
compared to the untreated diabetic control.  
The mechanism involved in the lowering of blood glucose 
levels by stevia could be due to modulation of glucose 
transport, or glucose disposal, or better insulin secretion. The 
results of the study showed an increase in the serum insulin 
level in the stevia and polyphenols extract groups. Perhaps 
stevia could enhance the number of beta cells of pancreatic 
islets in diabetic treated rats. The increase in insulin levels 
suggested that stevia would enhance the secretion of insulin 
from beta cells. 
Other compounds like vitamin E and vitamin C have been 
demonstrated to be antioxidants that scavenge the free 
radicals generated in cell membranes. According to other 
authors cited by Shivanna et al. (2013), the synergic effects 
between these two vitamins are particularly efficient for 
reducing production of reactive oxygen species. As cited by 
the author, tissue antioxidant concentrations such as vitamin 
E decreased due to its mobilization to blood in control 
diabetic rats. 
3.5. Flavonoids 
Flavonoids have proved to be potential antidiabetic agents by 
Pereira et al. (2011) because they exert multiple actions that 
are both hypoglycemic (insulinomimetic action) and 
antihyperglycemic (insulin secretagogue). Despite this, 
flavonoid action is dependent on the number, type, and 
position of glycosyl residues on the natural compounds. The 
actions of kaempferitrin and kaempferol-3-neohesperidoside 
were shown, providing strong evidence of stabilizing glucose 
homeostasis in diabetic rats. Quercetin and rutin actions were 
also investigated. Quercetin activates hexokinase and 
glucokinase and inhibits both glycogen phosphorylase and 
hepatic glucose-6-phosphatase. Shimizu et al. (2000) 
demonstrated a marked reduction in glucose absorption, after 
in vivo treatment by oral gavage. According to Pereira et al. 
(2011), other works reported that the inhibitory effect of 
quercetin on glucose absorption is due to the competitive 
inhibition of the sodium-dependent glucose transporter. 
Among the properties of rutin, an increase in insulin and C-
peptide serum levels is reported providing a protective effect 
on pancreatic β-cells, restoration of glycogen content and 
hexokinase activity, and decreased glucose-6-phosphatase 
and fructose-1, 6-biphosphatase activities. 
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Two flavonoids (acacetin and diosmetin) were isolated from 
an infusion of the plant Anoda cristata from Juarez-Reyes et 
al. (2015). The results demonstrated that the extracts and 
compounds were effective for reducing blood glucose levels, 
causing significant hypoglycemic effect and possess 
antioxidant capacity. This can be attributed to acacetin and its 
glycosides that exhibited also significant inhibitory activity 
against α-glycosidases which reduces the impact of 
carbohydrates on blood sugar. Babiaka et al. (2015) also 
observed with tests in vivo that flavonoids inhibit the 
carbohydrate hydrolysing enzyme α-glucosidase, confirming 
their hypoglycemic activities. 
Different components were extracted from mulberry leaves 
by Li et al. (2015), deoxynojirimycin (DNJ) and 
polysaccharide (P), to show their anti-hyperglycemic effect. 
They tested the components alone, but the results indicated 
that better results were obtained with a combination. The 
components were administrated in diabetic rats and the 
results were compared to a control group. The mixture 
decreased blood glucose after oral administration to diabetic 
mice for 90 d. The same treatment resulted in remarkable up-
regulation of the expression of the glycolysis enzymes 
(glucokinase, phosphofructokinase and pyruvate kinase) that 
were measured in the liver. Also, mice treated with the 
mixture presented significant reduction in pyruvate 
carboxylase, fructose-1, 6-biphosphatase and 
phosphoenolpyruvate carboxykinase levels, such as glucose-
6-phosphatase. This suggests that glucose-6-phosphatase is 
converted to glycogen, which results in attenuation of hepatic 
glucose outputs with the mixture treatment.  
Moreover, the decrease in blood glucose may be due to 
increased insulin secretion and peripheral glucose 
metabolism. To verify this hypothesis, the authors measured 
protein levels in pancreas and insulin resistance in tissues of 
the liver and muscle. As upregulation in protein level was 
observed and blood insulin concentrations were increased, 
they concluded that the mixture is able to restore the 
damaged pancreas to normalcy and DNJ increases β-cell 
proliferation. 
3.6. Other Components 
In addition to the common compounds already cited with 
hypoglycemic effect, there are two different classes known as 
limonoids and saponins that have been proved to be effective 
in hypoglycemic applications. Ovalle-Magallanes et al. 
(2015) isolated eight limonoids of the mexicanolide type 
from the hexane extract of Swietenia humilis to be evaluated 
in relation to their hypoglycemic and antihyperglycemic 
effects. The daily administration of the extract (100 mg/Kg) 
to rats during a week provoked a significant hypoglycemic 
effect, reducing serum triglycerides and uric acid without any 
changes in insulin levels suggesting that the mechanism 
involved an insulin sensitizing. An increase on glycogen 
content was also observed and a reduction in the abdominal 
fat in the rats. The reduction in blood triglycerides is 
compatible with an increase in glucose uptake in adipose 
tissue. The opposite behaviour was mentioned by De et al. 
(2011), who reported the effect of the oral administration of 
methanol extract of S. mahagoni, over 21 days, where it 
lowered the glycogen levels in diabetic rats. Dewanjee et al. 
(2009) also cited the effect of another limonoid, swietenine 
(25 and 50 mg/Kg), isolated from S. macrophylla, that 
showed a moderate hypoglycemic action in a diabetic rat 
model. 
It is important to notice that the compounds could act 
synergistically on different molecular targets to produce 
antidiabetic and hypolipidemic effects. Moreover, a mixture 
with other components present in the extract of the plant 
could enhance the bioavailability of one or several 
compounds in the extract, thus improving their 
pharmacological action. This is why some mechanisms were 
difficult to prove and are absent in the literature. Better 
understanding of the effects of the compounds can promote 
their use as natural products with the prospects of an increase 
in the quality of life of people suffering from diabetes. 
Flavones, sterols and terpenes are also important compounds 
for the hypoglycemic effect (Silva and Filho, 2002). 
Alexander-Lindo et al. (2004) isolated two compounds from 
the hexane extract of the bark of Anarcadium occidentale 
(cashew), stigmast-4-en-3-ol and stigmast-4-en-3-one. Both 
compounds produced significant hypoglycemic activity after 
intravenous administration at a dose of 1.3 mg/Kg body 
weight of dogs. Also, the intravenous administration of the 
hexane extract to normal healthy dogs produced a significant 
lowering of the blood glucose levels. The bark of the cashew 
plant exhibited a hypoglycemic effect probably due to the 
presence of these compounds. 
4. Bioactive Compounds 
Activates AMP-Activated 
Protein Kinase (AMPK) 
One of the most important mechanisms to stimulate insulin 
secretion is AMPK activation. This is known because AMPK 
is a key energy-sensing/signalling system in the cells and acts 
as a fuel gauge by monitoring cellular energy levels (Yin et 
al., 2012). It is so important because the activation of AMPK 
is well known to increase insulin sensitivity and regulate 
mitochondrial function (Kahn et al., 2005).  
Barnes et al. (2004) have reported that AMPK plays a key 
role in regulating carbohydrate and fat metabolism, serving 
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as a metabolic master switch in response to alterations in 
cellular energy charge. Yin et al. (2012) also reported that 
one of the mechanisms found in hypoglycemic activity 
components is AMP-activated protein kinase (AMPK) 
activation. 
There are few results that relate the AMPK activation to 
specific bioactive components. Catechins and berberine were 
investigated and their biological effect was proved. Tang et 
al. (2013) also concluded that GTE and BTE, because of the 
catechins present in GTE and theaflavins present in BTE, 
significantly attenuated the high glucose-induced insulin, 
reduced lipid accumulation, supressed fatty acid synthesis 
and stimulated fatty acid oxidation through the AMPK 
pathway in cultured cells (Murase et al., 2009). 
The presence of catechins was also evaluated by Vasconcelos 
et al. (2011) in the bark extract of Caesalpinia ferrea Martius 
and the molecular mechanisms that exert hypoglycemic 
action. The first mechanism is Akt activation that acts on 
glycogen synthase. Moreover Daisy et al. (2010) have shown 
that animals treated with catechins isolated from another 
plant (Cassia fistula) exhibited increased expression of 
GLUT4 even in the absence of regeneration of pancreatic β 
cells. 
Beyond all the active mechanisms of catechins, they still 
have a hepatoprotective effect against the increase of hepatic 
up take of amino acids. This behaviour was also cited by 
Tsuchiya et al. (2001) who proved that catechins improve the 
permeability of the hepatocyte membrane. Another 
mechanism, also cited by Zhou et al. (2001), is the reduced 
activation of AMPK and the increased activation of acetyl-
CoA carboxylase (ACC), which allow the oxidation of fatty 
acids in the skeletal muscle and in the liver of extract treated 
animals which suggests a restoration of the energy balance. 
This is explained by the low levels of total cholesterol, 
triglycerides and epididymal adipose tissue mass found in 
extract treated animals. 
Moreover, Babiaka et al. (2015) cited that epicatechin has 
some ability to lower glucose levels. 
Recently berberine was cited as a hypoglycemic compound 
due to its effect in the inhibition of mitochondrial function 
by stimulation of glycolysis and activation of AMPK 
pathway. It is able to lower blood insulin level via 
enhancing insulin sensitivity. However, in patients with 
poor β cell function, berberine may improve insulin 
secretion via resuscitating exhausted islets. It is said that it 
has many extra beneficial effects like cholesterol-lowering, 
as well as anti-arrhythmic and nitric oxide inducing 
properties (Yin et al., 2012).  
5. Effect of Bioactive 
Components in Liver 
Although the liver plays a central role in glucose metabolism, 
there are only two reported results showing the positive 
behaviour of the bioactive compounds on liver morphology. 
Tang et al. (2013) evaluated the liver morphology and 
compared the hypoglycemic effects of GTE and BTE for 
diabetic and normal mice. Liver histology revealed many 
accumulated lipid droplets in the cytoplasm of hepatocytes in 
diabetic mice, but very few in the control ones. GTE and 
BTE treatments ameliorated the damage to hepatocytes to 
different degrees. Their microphotograph of the liver from 
diabetic mice treated with GTE resembles a normal liver, 
probably due to the presence of catechins. The results from 
BTE improved from the diabetic group, however there were 
still considerable number of lipid droplets in the liver. 
Li et al. (2015) also evaluated the influence of the bioactive 
compounds in the liver and in hepatic cells. When observed 
under a microscope, normal hepatic cells have an irregular 
polygonal shape and form clusters adhering to the liver plate 
wall. The treatment with DNJ and P separately did not affect 
cell morphology. The cells incubated with streptozotocin 
significantly decreased in number and exhibit pathological 
changes such as a dark appearance and black spots. 
Treatment with the mixture of DNJ and P restored the shape 
and structural integrity of the damaged cells, confirming all 
of the works mentioned above that concluded that the main 
mechanism is the increase in the number of beta cells. 
6. Conclusions 
In summary, a considerable number of plants are traditionally 
used for the treatment of diabetes. Many of the mechanisms 
of the bioactive compounds are not known and therefore the 
use of natural products as drugs is still difficult.  
According to this review, it could be possible to find 
promising candidates for the treatment of diabetes mellitus 
that could be achieved through evaluation of the anti-diabetic 
properties of different extracts of the medicinal plants, their 
fractions and the isolated compounds. 
Alkaloids, saponins, vitamins, polyphenols, flavonoids, and 
limonoids could be isolated from the plant extracts and, 
based on this review, are promising oral hypoglycemic 
agents. The mechanism for regulating blood glucose and 
lipids has been presented and various animal models were 
presented. The major mechanisms are related to the 
activation of the AMPK pathway, insulin secretion and 
increase of number of beta cells of pancreatic islets (Figure 
1). A more detailed explanation of the mechanisms for each 
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bioactive compound is summarized in Figure 2. It is possible 
to observe that the main effects are the stimulation of insulin 
secretion and protective effect or regeneration of β-cell 
function. 
The knowledge of the main active mechanisms of the 
bioactive compounds present in hypoglycemic plants will 
allow representation of chemical reactions that occurred in 
diabetic and non-diabetic patients through mathematical 
modelling. The models will help with the prediction of the 
behaviour of bioactive compounds reducing the need for 
experimental animal models. 
 
Figure 1. Therapeutic effects of the extracts present in hypoglycemic plants. 
 
Figure 2. Possible active mechanisms of the bioactive compounds present in the medicinal plants. 
The identification of the mechanisms together with the 
bioactive components stimulate further investigations using 
mathematical modelling. Bioactive components that are 
responsible for the hypoglycemic effects can further develop 
modern anti-diabetic drugs. 
If we are able to ascertain the active mechanism of bioactive 
compounds present in hypoglycemic plants we can develop 
mathematical models to aid system understanding and help 
predict medical effects. 
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